WO2002008743A1 - Biocapteur - Google Patents
Biocapteur Download PDFInfo
- Publication number
- WO2002008743A1 WO2002008743A1 PCT/JP2001/006188 JP0106188W WO0208743A1 WO 2002008743 A1 WO2002008743 A1 WO 2002008743A1 JP 0106188 W JP0106188 W JP 0106188W WO 0208743 A1 WO0208743 A1 WO 0208743A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- working electrode
- counter electrode
- electrode
- supply path
- sample
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3272—Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
- C12Q1/006—Enzyme electrodes involving specific analytes or enzymes for glucose
Definitions
- the present invention relates to a biosensor for rapidly and accurately quantifying a substrate contained in a sample.
- Photometric, colorimetric, reductive titration, and various chromatographic methods have been developed for quantitative analysis of sugars such as sucrose and glucose.
- sugars such as sucrose and glucose.
- none of these methods has a very high specificity for saccharides, so that the accuracy is low.
- the photometer method among these methods the operation is simple, but it is greatly affected by the temperature during the operation. Therefore, the photometer method is not appropriate as a method for ordinary people to easily determine saccharides at home.
- GOD glucose oxidase
- GOD uses oxygen as an electron carrier to selectively oxidize the substrate i3-D-glucose to D_darcono (5-lactone.
- oxygen is reduced to hydrogen peroxide.
- the oxygen electrode measures the decrease in oxygen, or the hydrogen peroxide electrode measures the increase in hydrogen peroxide. Since the amount of decrease in oxygen and the amount of increase in hydrogen peroxide are proportional to the content of glucose in the sample, glucose can be quantified from the amount of decrease in oxygen or the amount of increase in hydrogen peroxide.
- glucose in the sample can be accurately quantified by utilizing the specificity of the enzyme reaction.
- the measurement result has the disadvantage that it is greatly affected by the oxygen concentration contained in the sample, and measurement becomes impossible if oxygen does not exist in the sample. Therefore, a new type of glucose sensor has been developed which does not use oxygen as an electron carrier but uses an organic compound or metal complex such as potassium ferricyanide, a fecacene derivative or a quinone derivative as an electron carrier.
- the reduced form of the electron carrier generated as a result of the enzyme reaction is oxidized on the working electrode, and the concentration of glucose contained in the sample can be determined from the oxidation current.
- a reagent layer can be formed by accurately supporting a known amount of GOD and those electron carriers on an electrode in a stable state. This makes it possible to accurately determine glucose without being affected by the oxygen concentration in the sample.
- a reagent layer containing an enzyme and an electron mediator can be integrated with the electrode system in a nearly dry state, a disposable glucose sensor based on this technology has attracted much attention in recent years. ing.
- a typical example is a biosensor disclosed in Japanese Patent No. 2517153. In a disposable glucose sensor, it is detachably connected to a measuring instrument. The glucose concentration can be easily measured with a measuring device simply by introducing the sample into the sensor.
- an object of the present invention is to provide a high-sensitivity biosensor that requires a small amount of sample for measurement. Disclosure of the invention
- the biosensor of the present invention includes: a first insulating substrate having a working electrode; a second insulating substrate having a counter electrode opposed to the working electrode; a reagent layer containing at least an oxidoreductase; Formed between two insulating substrates Characterized in that the working electrode, the counter electrode and the reagent layer are exposed in the sample supply path, and the distance between the working electrode and the counter electrode is 150 zm or less. .
- the area of the part of the counter electrode exposed to the sample supply path is equal to or less than the area of the part of the working electrode exposed to the sample supply path, and the counter electrode is located immediately above the working electrode. Is preferably located.
- the working electrode the area of the portion exposed to the sample supply path S i is 0. 0 1 ⁇ 2.0 mm 2, more preferably 0. 1 ⁇ 2. 0 mm 2, is exposed to the sample supply path of the counter electrode area S 2 is 0. 0 0 5 ⁇ 2 0mm 2 parts, more preferably 0. 0 5 ⁇ 2. 0 mm 2 , preferably a S 2 ⁇ S.
- FIG. 1 is an exploded perspective view of a glucose sensor according to an embodiment of the present invention, from which a reagent layer and a surfactant layer have been removed.
- FIG. 2 is a longitudinal sectional view of the glucose sensor.
- FIG. 3 is an exploded perspective view of a glucose sensor according to another embodiment of the present invention, from which a reagent layer and a surfactant layer have been removed.
- FIG. 4 is an exploded perspective view of a glucose sensor according to still another embodiment of the present invention, from which a reagent layer and a surfactant layer have been removed.
- FIG. 5 is a longitudinal sectional view of the glucose sensor.
- FIG. 6 is an exploded perspective view of a glucose sensor according to still another embodiment of the present invention, from which a reagent layer and a surfactant layer have been removed.
- FIG. 7 is a longitudinal sectional view of the glucose sensor.
- FIG. 8 shows the glucose sensor of the comparative example without the reagent layer and surfactant layer.
- FIG. 4 is an exploded perspective view.
- FIG. 9 is a longitudinal sectional view of the glucose sensor.
- FIG. 10 is a graph showing the relationship between the sample supply path height and the response current value (ratio) of the glucose sensor of Example 1 of the present invention.
- FIG. 11 is a graph showing the relationship between the working electrode pair distance and the response current value (ratio) of the glucose sensor of Example 2 of the present invention.
- FIG. 12 is a graph showing the relationship between the distance between one working electrode and one working electrode and the response current value (ratio) of the glucose sensor according to the third embodiment of the present invention.
- the biosensor of the present invention includes a first insulating substrate having a working electrode, a second insulating substrate having a counter electrode opposed to the working electrode, and a reagent layer containing at least an oxidoreductase. And a sample supply path formed between the first and second insulating substrates, wherein the working electrode, the counter electrode, and the reagent layer are exposed in the sample supply path, and the working electrode, the counter electrode, Is less than 150 m.
- the distance between the working electrode and the counter electrode is preferably from 40 to 150 m, and more preferably from 40 to 100 m.
- the amount of the sample liquid stored in the sample supply path by capillary action is preferably 10 n1 to 5 Z1, and more preferably 50 ⁇ 1 to 50 Z1. 0 ⁇ 1.
- the area S 2 of the portion of the counter electrode exposed to the sample supply path is equal to or less than the area S of the portion of the working electrode exposed to the sample supply path, and Preferably, the counter electrode is located immediately above the working electrode.
- that the counter electrode is located immediately above the working electrode means that the entire counter electrode is formed so as to overlap the working electrode when viewed from the vertical direction of the working electrode.
- the area of the counter electrode is made larger than the area of the working electrode so that the reaction at the counter electrode does not become rate-determining.
- the area of the counter electrode becomes equal to the area of the working electrode. It is thought that the concentration of the redox species near the counter electrode will be higher because the current density on the counter electrode will be higher than when it is larger than the case. Since the sensor response depends on the concentration of the redox species in the vicinity of the counter electrode, the substrate can be quantified with high sensitivity as a result.
- the volume of the sample supply path can be reduced with the decrease in the area of the counter electrode, so that the sample amount can be reduced.
- the area of the counter electrode is preferably smaller than the area of the working electrode.
- the working electrode is formed on the first insulating substrate, and the counter electrode is formed on the second insulating substrate. This facilitates the biosensor manufacturing process.
- the first substrate and the second substrate have a structure that sandwiches the spacer member. In this way, the strength against the physical pressure on the substrate is increased, so that a short circuit due to contact between the working electrode and the counter electrode can be prevented, and the effect of the physical pressure on the current response is reduced. be able to.
- any material can be used as long as it has electrical insulation properties and has sufficient rigidity during storage and measurement.
- polyethylene, polystyrene, polyvinyl chloride, polyamide examples include thermoplastic resins such as Japanese polyester resins, and thermosetting resins such as urea resins, melamine resins, phenol resins, epoxy resins, and unsaturated polyester resins.
- thermoplastic resins such as Japanese polyester resins
- thermosetting resins such as urea resins, melamine resins, phenol resins, epoxy resins, and unsaturated polyester resins.
- polyethylene terephthalate is preferred from the viewpoint of adhesion to the electrode.
- any material having electrical insulation properties and sufficient rigidity during storage and measurement can be used.
- examples include thermoplastic resins such as polyethylene, polystyrene, polyvinyl chloride, polyamide, and saturated polyester resins, and thermosetting resins such as urea resins, melamine resins, phenol resins, epoxy resins, and unsaturated polyester resins.
- thermoplastic resins such as polyethylene, polystyrene, polyvinyl chloride, polyamide, and saturated polyester resins
- thermosetting resins such as urea resins, melamine resins, phenol resins, epoxy resins, and unsaturated polyester resins.
- the working electrode any conductive material that does not oxidize itself when oxidizing the electron carrier can be used.
- As the counter electrode any commonly used conductive material such as palladium, gold, platinum, and carbon can be used.
- the oxidoreductase one corresponding to the substrate to be measured contained in the sample is used.
- fructosidase dehydrogenase darcosoxidase, glucose dehydrogenase, alcoholoxidase, lactate oxidase, cholesterol oxidase, xanthine oxidase, amino acid oxidase and the like.
- the biosensor of the present invention preferably contains an electron carrier in the reagent layer.
- the electron carrier include potassium ferricyanide, P-benzoquinone, phenazine methosulfate, methylene blue, and a ferrocene derivative. Can be exacerbated. In addition, a current response can be obtained even when oxygen is used as the electron carrier. One or more of these electron carriers are used.
- the reagent layer preferably contains a hydrophilic polymer.
- Various polymers can be used as the hydrophilic polymer.
- Hydroxyethyl cellulose, hydroxypropyl cellulose, methyl Polyamino acids such as cellulose, ethylcellulose, ethylhydroxyethylcellulose, carboxymethylcellulose, polyvinylpyrrolidone, polyvinylalcohol, polylysine, polystyrenesulfonic acid, gelatin and its derivatives, polyacrylic acid and its salts, and polymethacrylic acid And its salts, starch and its derivatives, and maleic anhydride or its polymers.
- carboxymethyl cellulose, hydroxyethyl cellulose, and hydroxypropyl cellulose are preferred.
- FIG. 1 is an exploded perspective view of the glucose sensor according to the present embodiment excluding a reagent layer and a surfactant layer
- FIG. 2 is a longitudinal sectional view thereof.
- Reference numeral 11 denotes a first electrically insulating substrate made of polyethylene terephthalate.
- a silver paste is printed on the substrate 11 by screen printing to form a working electrode lead 12 and a base for the electrode. Then, a conductive carbon paste containing a resin binder is printed on the lower surface of the electrode.
- Working electrode 14 is formed. The working electrode 14 is in contact with the working electrode lead 12.
- An insulating layer 16 is formed on the substrate 11 by printing an insulating paste. The insulating layer 16 covers the outer periphery of the working electrode 14, thereby keeping the area of the exposed portion of the working electrode 14 constant.
- a silver paste is printed on the back surface of the second electrically insulating substrate 21.
- the counter electrode lead 23 and the base of the electrode are formed, and then a conductive carbon base is printed on the lower surface of the electrode to form the counter electrode 25.
- the area of the exposed portion of the counter electrode 25 is
- the insulating layer 27 is formed by printing an insulating paste so as to be larger than the area of the exposed portion of FIG. Air holes 29 are formed in the substrate 21.
- aqueous solution containing GOD, which is an enzyme, and a ferricyanide rim of an electron carrier is dropped on the working electrode 14 of the substrate 11, and then dried to form a reagent layer 10. Further, a surfactant layer 20 containing lecithin, which is a surfactant, is formed on the reagent layer 10.
- the glucose sensor as shown in FIG. 2 is assembled by bonding the substrate 11, the substrate 21, and the spacer member 17 in a positional relationship as shown by a dashed line in FIG.
- the spacer member 17 sandwiched between the substrate 11 and the substrate 21 has a slit 18.
- the slit 18 is provided between the substrates 11 and 21 and the sample supply path. A space portion is formed.
- FIG. 3 is a perspective view of the glucose sensor according to the present embodiment excluding the reagent layer and the surfactant layer.
- the counter electrode 25a is the same as the working electrode 14 (having a square shape and the area is equal to that of the working electrode. Others are the same as those of the first embodiment. Embodiment 3
- FIG. 4 is a perspective view of the talcose sensor according to the present embodiment excluding the reagent layer and the surfactant layer
- FIG. 5 is a longitudinal sectional view thereof.
- This glucose sensor is manufactured by the following procedure.
- palladium is sputtered on an electrically insulating substrate 31 having rising pieces 37, 37 on both sides to form a working electrode 34 and its lead 32.
- an insulating member 36 on the substrate 31, the working electrode 34 and the terminal portion of the lead 32 inserted into the measuring instrument are defined.
- palladium is also similarly sputtered on the inner surface of the second electrically insulating substrate 41 to produce a counter electrode 45 and a counter electrode lead 43.
- an insulating member 47 to the inner surface of the substrate 41, the counter electrode 45 and the terminal portion of the lead 43 to be inserted into the measuring instrument are defined.
- the second substrate is bonded to the substrate 31.
- the working electrode 34 and the counter electrode 45 are arranged at positions facing each other via a space formed between the substrate 31 and the substrate 41.
- the distance between the working electrode and the counter electrode is, for example, 100 m.
- the reagent layer 30 and the surfactant layer 40 are formed so as to cover the electrode 34 in the same manner as in the first embodiment.
- the end face closer to the electrodes 34 and 45 becomes the sample supply port 39.
- the sample supplied from here reaches the electrode portion by capillary action in the space connected to the air hole 49.
- FIG. 6 is a perspective view of the glucose sensor according to the present embodiment excluding the reagent layer and the surfactant layer
- FIG. 7 is a longitudinal sectional view thereof.
- This glucose sensor is manufactured by the following procedure. Palladium is sputtered on the first electrically insulating substrate 51 to form a working electrode 54 and its lead 52. Next, by attaching an insulating member 56 on the substrate 51, the working electrode 54 and the terminal portion of the lead 52 to be inserted into the measuring instrument are defined. On the other hand, on the inner wall surface of the curved surface portion 68 of the second electrically insulating substrate 61 having the curved surface portion 68 bulging outward, a parameter is sputtered to form a counter electrode 65 and its lead 63. I do. By adjusting the curvature of the curved surface portion 68, the distance between the working electrode 54 and the counter electrode 65 can be controlled.
- the counter electrode 65 and the terminal portion to be inserted into the measuring instrument are defined.
- the area of the counter electrode 65 is made equal to the area of the working electrode 54.
- the terminal of the counter electrode 65 is exposed on the rear surface of the rear end 61 a of the substrate 61.
- the curved portion 68 has an air hole 69 at an end thereof.
- a reagent layer 50 is formed on the working electrode 54, and a surfactant layer 60 is formed so as to cover the reagent layer 50.
- the substrate 51 and the substrate 61 are attached to assemble a glucose sensor.
- the area of the working electrode is 1.0 mm 2 .
- the counter electrode is a circle having a diameter of about 3.6 mm, but its diameter is larger than the width of the slit 18 of the spacer member 17, so that a part of the counter electrode is not exposed to the sample supply path.
- the area of the part exposed to the sample supply channel at the counter electrode is about 5.3 mm 2 .
- FIG. 9 is an exploded perspective view excluding the adhesive agent layer, and FIG. 9 is a longitudinal sectional view thereof.
- a silver paste is printed by screen printing on an electrically insulating substrate 101 made of polyethylene terephthalate to form a working electrode lead 102 and a counter electrode lead 103, and then a conductive material containing a resin binder.
- the working electrode 104 was formed by printing a conductive carbon paste.
- the working electrode 104 is in contact with the working electrode lead 102.
- an insulating paste was formed on the substrate 101 by printing an insulating paste.
- the insulating layer 106 covers the outer periphery of the working electrode 104, thereby keeping the area of the exposed portion of the working electrode 104 constant.
- a conductive adhesive paste containing a resin binder was printed on the substrate 101 so as to be in contact with the counter electrode lead 103 to form a counter electrode 105.
- Working electrode 104 has an area of 1.0 mm 2 , counter electrode
- the area of the portion exposed to the sample supply path of 105 is about 4.3 mm 2 .
- An aqueous solution containing the GOD of the enzyme and the ferricyanidation sphere of the electron mediator was dropped on the working electrode 104 and the counter electrode 105, and then dried to form a reagent layer.
- the cover 1 1 1 having the 1 1 4 and the spacer 1 1 10 having the slit 1 1 1 were adhered in a positional relationship as shown by a dashed line in Fig. 8.
- the glucose concentration of an aqueous solution containing a certain amount of glucose was measured by using the sensor described above.
- the sample was supplied from the sample supply port to the sample supply path, and after a certain period of time, a voltage of 500 mV was applied to the working electrode with reference to the counter electrode. When a current value flowing between the working electrode and the counter electrode was measured by applying the voltage, a current response proportional to the glucose concentration in the sample was observed.
- FIG. 10 shows the relationship between the height of the sample supply path and the response value (ratio) by the sensor of the first embodiment.
- the response value (ratio) is shown as a ratio where the response value of the sensor of the comparative example having the same sample supply path height is 100.
- Example 2 when the height of the sample supply path is set to 150 m or less, the response value (ratio) of Example 1 to the comparative example sharply increases. This is because if the working electrode and the counter electrode face each other and the distance between the working electrode and the counter electrode is 150 m or less, the growth of the diffusion layer of the redox species at the working electrode is suppressed, and This is considered to be due to the fact that the concentration of the redox species is reflected in the sensor response, and that the charge transfer between the working electrode and one of the electrodes is improved.
- the distance between the working electrode and the working electrode is limited, so that the sample amount required for the measurement can be reduced.
- a biosensor was produced in the same manner as in Example 1 except that the working electrode and the counter electrode were each set to have a surface area of 1.0 mm 2 . Then, the response current value of the solution containing 9 O.mg Zd1 of glucose was measured by each glucose sensor having a different height of the sample supply path.
- FIG. 11 shows the relationship between the height of the sample supply path by the sensor of the second embodiment, that is, the distance between the working electrode pair and the response value (ratio).
- the response value (ratio) is represented by a ratio where the response value of the sensor of Example 1 having the same height of the sample supply path is set to 100.
- the response value (ratio) of the sensor of Example 2 to Example 1 increases rapidly. ing. This is because when the working electrode and the counter electrode face each other and the distance between the working electrode and the counter electrode is less than 150 m, the growth of the diffusion layer of the redox species at the working electrode is suppressed, and It is thought that this is because the concentration of the redox species is reflected in the sensor response, and the charge transfer between the working electrode and the working electrode is improved.
- the area of the counter electrode is made larger than the area of the working electrode to prevent the reaction at the counter electrode from being rate-limiting.
- the working electrode and the counter electrode are arranged opposite to each other, the current density on the counter electrode is reflected in the current response, etc., so that the area of the counter electrode is larger than that of the working electrode. It is considered that a high response current was obtained.
- FIG. 12 shows the relationship between the height of the sample supply path (distance between the working electrode and the counter electrode) and the response value (ratio) by the sensor of the third embodiment.
- the response value (ratio) is shown as a ratio where the response value of the sensor of Example 1 having the same height of the sample supply path is 100.
- the response value (ratio) of Example 1 to Example 1 sharply increases. This is considered to be due to the same reason as described in the second embodiment.
- the area of the counter electrode is smaller than that of the working electrode.
- the position of the air hole can be made closer to the sample supply port side. Therefore, it is possible to further reduce the amount of sample required for the measurement compared to the second embodiment.
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002514386A JP4177662B2 (ja) | 2000-07-24 | 2001-07-17 | バイオセンサ |
DE60140000T DE60140000D1 (en) | 2000-07-24 | 2001-07-17 | Biosensor |
EP01948050A EP1304566B1 (en) | 2000-07-24 | 2001-07-17 | Biosensor |
US10/220,153 US6885196B2 (en) | 2000-07-24 | 2001-07-17 | Biosensor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-222266 | 2000-07-24 | ||
JP2000222266 | 2000-07-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002008743A1 true WO2002008743A1 (fr) | 2002-01-31 |
Family
ID=18716530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2001/006188 WO2002008743A1 (fr) | 2000-07-24 | 2001-07-17 | Biocapteur |
Country Status (7)
Country | Link |
---|---|
US (1) | US6885196B2 (ja) |
EP (1) | EP1304566B1 (ja) |
JP (1) | JP4177662B2 (ja) |
CN (1) | CN100339701C (ja) |
DE (1) | DE60140000D1 (ja) |
ES (1) | ES2331689T3 (ja) |
WO (1) | WO2002008743A1 (ja) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1382968A1 (en) * | 2002-07-18 | 2004-01-21 | Matsushita Electric Industrial Co., Ltd. | Measuring apparatus with a biosensor |
JP2005043345A (ja) * | 2003-06-12 | 2005-02-17 | Bayer Healthcare Llc | 毛管充填診断センサのセンサフォーマット及び構成方法 |
JP2006010352A (ja) * | 2004-06-22 | 2006-01-12 | Sumitomo Electric Ind Ltd | センサチップ及びその製造方法 |
JPWO2004061444A1 (ja) * | 2002-12-20 | 2006-05-18 | アークレイ株式会社 | 薄型分析用具 |
JP2007232628A (ja) * | 2006-03-02 | 2007-09-13 | National Institute Of Advanced Industrial & Technology | バイオセンサー |
JP2007316031A (ja) * | 2006-05-29 | 2007-12-06 | Fujitsu Ltd | 電気化学セル及び電位印加方法 |
WO2010137266A1 (ja) * | 2009-05-29 | 2010-12-02 | パナソニック株式会社 | バイオセンサシステム及び分析物の濃度の測定方法 |
US7906000B2 (en) | 2004-04-23 | 2011-03-15 | Arkray, Inc. | Analyzer and method of manufacturing the same |
US8268145B2 (en) | 2004-05-21 | 2012-09-18 | Agamatrix, Inc. | Electrochemical cell and method of making an electrochemical cell |
WO2014050421A1 (ja) * | 2012-09-25 | 2014-04-03 | 東レ株式会社 | 配線パターンの形成方法および配線パターン形成物 |
KR20180006968A (ko) * | 2015-06-15 | 2018-01-19 | 에프. 호프만-라 로슈 아게 | 체액의 샘플에서 적어도 하나의 분석물을 전기 화학적으로 검출하기 위한 방법 및 테스트 엘리먼트 |
Families Citing this family (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69809391T2 (de) | 1997-02-06 | 2003-07-10 | Therasense Inc | Kleinvolumiger sensor zur in-vitro bestimmung |
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US7390667B2 (en) * | 1997-12-22 | 2008-06-24 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using AC phase angle measurements |
US7407811B2 (en) * | 1997-12-22 | 2008-08-05 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using AC excitation |
US8071384B2 (en) | 1997-12-22 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Control and calibration solutions and methods for their use |
US6103033A (en) | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US6294281B1 (en) * | 1998-06-17 | 2001-09-25 | Therasense, Inc. | Biological fuel cell and method |
US6338790B1 (en) | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US20050103624A1 (en) * | 1999-10-04 | 2005-05-19 | Bhullar Raghbir S. | Biosensor and method of making |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US7005273B2 (en) * | 2001-05-16 | 2006-02-28 | Therasense, Inc. | Method for the determination of glycated hemoglobin |
EP1404234B1 (en) | 2001-06-12 | 2011-02-09 | Pelikan Technologies Inc. | Apparatus for improving success rate of blood yield from a fingerstick |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
DE60234598D1 (de) | 2001-06-12 | 2010-01-14 | Pelikan Technologies Inc | Selbstoptimierende lanzettenvorrichtung mit adaptationsmittel für zeitliche schwankungen von hauteigenschaften |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
ATE485766T1 (de) | 2001-06-12 | 2010-11-15 | Pelikan Technologies Inc | Elektrisches betätigungselement für eine lanzette |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7749174B2 (en) | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US7052591B2 (en) * | 2001-09-21 | 2006-05-30 | Therasense, Inc. | Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking |
AU2002356956A1 (en) * | 2001-11-16 | 2003-06-10 | North Carolina State University | Biomedical electrochemical sensor array and method of fabrication |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US6743635B2 (en) * | 2002-04-25 | 2004-06-01 | Home Diagnostics, Inc. | System and methods for blood glucose sensing |
US20080112852A1 (en) * | 2002-04-25 | 2008-05-15 | Neel Gary T | Test Strips and System for Measuring Analyte Levels in a Fluid Sample |
US6964871B2 (en) | 2002-04-25 | 2005-11-15 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
US6946299B2 (en) | 2002-04-25 | 2005-09-20 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
US7368190B2 (en) | 2002-05-02 | 2008-05-06 | Abbott Diabetes Care Inc. | Miniature biological fuel cell that is operational under physiological conditions, and associated devices and methods |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
DK1633235T3 (da) | 2003-06-06 | 2014-08-18 | Sanofi Aventis Deutschland | Apparat til udtagelse af legemsvæskeprøver og detektering af analyt |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
US7452457B2 (en) * | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
PT1639352T (pt) | 2003-06-20 | 2018-07-09 | Hoffmann La Roche | Método e reagente para produzir tiras de reagente homogéneas, estreitas |
US7718439B2 (en) | 2003-06-20 | 2010-05-18 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US8058077B2 (en) | 2003-06-20 | 2011-11-15 | Roche Diagnostics Operations, Inc. | Method for coding information on a biosensor test strip |
US7645373B2 (en) * | 2003-06-20 | 2010-01-12 | Roche Diagnostic Operations, Inc. | System and method for coding information on a biosensor test strip |
US8148164B2 (en) * | 2003-06-20 | 2012-04-03 | Roche Diagnostics Operations, Inc. | System and method for determining the concentration of an analyte in a sample fluid |
US7597793B2 (en) * | 2003-06-20 | 2009-10-06 | Roche Operations Ltd. | System and method for analyte measurement employing maximum dosing time delay |
US7645421B2 (en) * | 2003-06-20 | 2010-01-12 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US8071030B2 (en) * | 2003-06-20 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Test strip with flared sample receiving chamber |
US8679853B2 (en) * | 2003-06-20 | 2014-03-25 | Roche Diagnostics Operations, Inc. | Biosensor with laser-sealed capillary space and method of making |
US8206565B2 (en) | 2003-06-20 | 2012-06-26 | Roche Diagnostics Operation, Inc. | System and method for coding information on a biosensor test strip |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
EP1680014A4 (en) | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | METHOD AND APPARATUS PROVIDING A VARIABLE USER INTERFACE |
US7299082B2 (en) | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US8165651B2 (en) * | 2004-02-09 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte sensor, and associated system and method employing a catalytic agent |
US7699964B2 (en) * | 2004-02-09 | 2010-04-20 | Abbott Diabetes Care Inc. | Membrane suitable for use in an analyte sensor, analyte sensor, and associated method |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | METHOD AND APPARATUS FOR MANUFACTURING A DEVICE FOR SAMPLING LIQUIDS |
US7556723B2 (en) * | 2004-06-18 | 2009-07-07 | Roche Diagnostics Operations, Inc. | Electrode design for biosensor |
US7569126B2 (en) | 2004-06-18 | 2009-08-04 | Roche Diagnostics Operations, Inc. | System and method for quality assurance of a biosensor test strip |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
US7922985B2 (en) * | 2008-06-24 | 2011-04-12 | Lifescan, Inc. | Analyte test strip for accepting diverse sample volumes |
US8178313B2 (en) * | 2008-06-24 | 2012-05-15 | Lifescan, Inc. | Method for determining an analyte in a bodily fluid |
US8187658B2 (en) * | 2008-06-24 | 2012-05-29 | Lifescan, Inc. | Method of manufacturing analyte test strip for accepting diverse sample volumes |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US20100213057A1 (en) | 2009-02-26 | 2010-08-26 | Benjamin Feldman | Self-Powered Analyte Sensor |
US8437827B2 (en) * | 2009-06-30 | 2013-05-07 | Abbott Diabetes Care Inc. | Extruded analyte sensors and methods of using same |
US8298158B2 (en) * | 2009-06-30 | 2012-10-30 | Abbott Diabetes Care Inc. | Integrated devices having extruded electrode structures and methods of using same |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
CA2933166C (en) | 2013-12-31 | 2020-10-27 | Abbott Diabetes Care Inc. | Self-powered analyte sensor and devices using the same |
JP6754259B2 (ja) * | 2015-10-15 | 2020-09-09 | アークレイ株式会社 | バイオセンサ、及びその製造方法 |
KR102088277B1 (ko) * | 2018-04-27 | 2020-03-13 | 주식회사 유니언스진 | 면역 화학 진단법을 이용한 표적 항원 검출용 종이기반 3차원 구조의 미세칩과 이를 이용한 표적항원 검출 방법 |
TWI768560B (zh) * | 2020-11-25 | 2022-06-21 | 五鼎生物技術股份有限公司 | 生化試片 |
US20230408437A1 (en) * | 2022-05-18 | 2023-12-21 | Apex Biotechnology Corp. | Electrochemical system and implantable biochemical test chip |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0685737A1 (en) * | 1994-06-02 | 1995-12-06 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method for producing the same |
JPH09159642A (ja) * | 1995-12-04 | 1997-06-20 | Dainippon Printing Co Ltd | バイオセンサ及びその製造方法 |
JPH102874A (ja) * | 1996-06-14 | 1998-01-06 | Nok Corp | グルコースバイオセンサ |
EP0964059A2 (en) * | 1998-06-11 | 1999-12-15 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
EP0969282A2 (en) * | 1998-07-02 | 2000-01-05 | Nec Corporation | An enzyme electrode and a biosensor and a measuring apparatus therewith |
JP2000065777A (ja) * | 1998-08-21 | 2000-03-03 | Nok Corp | バイオセンサ |
JP2000258382A (ja) * | 1999-03-05 | 2000-09-22 | Arkray Inc | 検体少量型バイオセンサ |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2517153B2 (ja) | 1989-09-21 | 1996-07-24 | 松下電器産業株式会社 | バイオセンサおよびその製造法 |
EP0505494B1 (en) | 1989-12-15 | 1995-07-12 | Boehringer Mannheim Corporation | Redox mediator reagent and biosensor |
US5508171A (en) * | 1989-12-15 | 1996-04-16 | Boehringer Mannheim Corporation | Assay method with enzyme electrode system |
US5437999A (en) * | 1994-02-22 | 1995-08-01 | Boehringer Mannheim Corporation | Electrochemical sensor |
US6413410B1 (en) * | 1996-06-19 | 2002-07-02 | Lifescan, Inc. | Electrochemical cell |
JP3370504B2 (ja) * | 1996-03-13 | 2003-01-27 | 松下電器産業株式会社 | バイオセンサ |
DE69809391T2 (de) | 1997-02-06 | 2003-07-10 | Therasense Inc | Kleinvolumiger sensor zur in-vitro bestimmung |
US6656702B1 (en) | 1998-07-03 | 2003-12-02 | Matsushita Electric Industrial Co., Ltd. | Biosensor containing glucose dehydrogenase |
JP3267936B2 (ja) | 1998-08-26 | 2002-03-25 | 松下電器産業株式会社 | バイオセンサ |
-
2001
- 2001-07-17 JP JP2002514386A patent/JP4177662B2/ja not_active Expired - Lifetime
- 2001-07-17 WO PCT/JP2001/006188 patent/WO2002008743A1/ja active Application Filing
- 2001-07-17 US US10/220,153 patent/US6885196B2/en not_active Expired - Lifetime
- 2001-07-17 CN CNB018090451A patent/CN100339701C/zh not_active Expired - Lifetime
- 2001-07-17 DE DE60140000T patent/DE60140000D1/de not_active Expired - Lifetime
- 2001-07-17 EP EP01948050A patent/EP1304566B1/en not_active Expired - Lifetime
- 2001-07-17 ES ES01948050T patent/ES2331689T3/es not_active Expired - Lifetime
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0685737A1 (en) * | 1994-06-02 | 1995-12-06 | Matsushita Electric Industrial Co., Ltd. | Biosensor and method for producing the same |
JPH09159642A (ja) * | 1995-12-04 | 1997-06-20 | Dainippon Printing Co Ltd | バイオセンサ及びその製造方法 |
JPH102874A (ja) * | 1996-06-14 | 1998-01-06 | Nok Corp | グルコースバイオセンサ |
EP0964059A2 (en) * | 1998-06-11 | 1999-12-15 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
EP0969282A2 (en) * | 1998-07-02 | 2000-01-05 | Nec Corporation | An enzyme electrode and a biosensor and a measuring apparatus therewith |
JP2000065777A (ja) * | 1998-08-21 | 2000-03-03 | Nok Corp | バイオセンサ |
JP2000258382A (ja) * | 1999-03-05 | 2000-09-22 | Arkray Inc | 検体少量型バイオセンサ |
Non-Patent Citations (1)
Title |
---|
See also references of EP1304566A4 * |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6969450B2 (en) | 2002-07-18 | 2005-11-29 | Matsushita Electric Industrial Co., Ltd. | Biosensor and measuring apparatus for biosensor |
EP1382968A1 (en) * | 2002-07-18 | 2004-01-21 | Matsushita Electric Industrial Co., Ltd. | Measuring apparatus with a biosensor |
JPWO2004061444A1 (ja) * | 2002-12-20 | 2006-05-18 | アークレイ株式会社 | 薄型分析用具 |
JP2005043345A (ja) * | 2003-06-12 | 2005-02-17 | Bayer Healthcare Llc | 毛管充填診断センサのセンサフォーマット及び構成方法 |
US7906000B2 (en) | 2004-04-23 | 2011-03-15 | Arkray, Inc. | Analyzer and method of manufacturing the same |
US10203298B2 (en) | 2004-05-21 | 2019-02-12 | Agamatrix, Inc. | Electrochemical cell and method of making an electrochemical cell |
US9329150B2 (en) | 2004-05-21 | 2016-05-03 | Agamatrix, Inc. | Electrochemical cell and method of making an electrochemical cell |
US8268145B2 (en) | 2004-05-21 | 2012-09-18 | Agamatrix, Inc. | Electrochemical cell and method of making an electrochemical cell |
JP2006010352A (ja) * | 2004-06-22 | 2006-01-12 | Sumitomo Electric Ind Ltd | センサチップ及びその製造方法 |
JP2007232628A (ja) * | 2006-03-02 | 2007-09-13 | National Institute Of Advanced Industrial & Technology | バイオセンサー |
JP4635258B2 (ja) * | 2006-03-02 | 2011-02-23 | 独立行政法人産業技術総合研究所 | バイオセンサー |
JP2007316031A (ja) * | 2006-05-29 | 2007-12-06 | Fujitsu Ltd | 電気化学セル及び電位印加方法 |
JP2013156270A (ja) * | 2009-05-29 | 2013-08-15 | Panasonic Corp | バイオセンサシステム及び分析物の濃度の測定方法 |
JP2013167637A (ja) * | 2009-05-29 | 2013-08-29 | Panasonic Corp | バイオセンサシステム及び分析物の濃度の測定方法 |
KR101337704B1 (ko) * | 2009-05-29 | 2013-12-06 | 파나소닉 주식회사 | 바이오 센서 시스템 및 분석물의 농도의 측정 방법 |
JP5422647B2 (ja) * | 2009-05-29 | 2014-02-19 | パナソニック株式会社 | バイオセンサシステム及び分析物の濃度の測定方法 |
WO2010137266A1 (ja) * | 2009-05-29 | 2010-12-02 | パナソニック株式会社 | バイオセンサシステム及び分析物の濃度の測定方法 |
US9476849B2 (en) | 2009-05-29 | 2016-10-25 | Panasonic Healthcare Holdings Co., Ltd. | Biosensor system and method for measuring concentration of analyte |
US10295496B2 (en) | 2009-05-29 | 2019-05-21 | Phc Holdings Corporation | Method for measuring concentration of analyte |
WO2014050421A1 (ja) * | 2012-09-25 | 2014-04-03 | 東レ株式会社 | 配線パターンの形成方法および配線パターン形成物 |
KR20180006968A (ko) * | 2015-06-15 | 2018-01-19 | 에프. 호프만-라 로슈 아게 | 체액의 샘플에서 적어도 하나의 분석물을 전기 화학적으로 검출하기 위한 방법 및 테스트 엘리먼트 |
KR102119301B1 (ko) | 2015-06-15 | 2020-06-05 | 에프. 호프만-라 로슈 아게 | 체액의 샘플에서 적어도 하나의 분석물을 전기 화학적으로 검출하기 위한 방법 및 테스트 엘리먼트 |
Also Published As
Publication number | Publication date |
---|---|
ES2331689T3 (es) | 2010-01-13 |
DE60140000D1 (en) | 2009-11-05 |
US20030032875A1 (en) | 2003-02-13 |
CN1522365A (zh) | 2004-08-18 |
US6885196B2 (en) | 2005-04-26 |
JP4177662B2 (ja) | 2008-11-05 |
EP1304566A1 (en) | 2003-04-23 |
EP1304566B1 (en) | 2009-09-23 |
JPWO2002008743A1 (ja) | 2004-04-22 |
CN100339701C (zh) | 2007-09-26 |
EP1304566A4 (en) | 2004-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4177662B2 (ja) | バイオセンサ | |
EP1126032B1 (en) | Biosensor | |
EP1113264B1 (en) | Biosensor | |
JP3267936B2 (ja) | バイオセンサ | |
JP3389106B2 (ja) | 電気化学分析素子 | |
US6416641B1 (en) | Biosensor | |
JP3690683B2 (ja) | バイオセンサ | |
JP3102627B2 (ja) | バイオセンサ、それを用いた定量法および定量装置 | |
JPH1142098A (ja) | 基質の定量法 | |
JP2001330581A (ja) | 基質濃度定量法 | |
JP3267933B2 (ja) | 基質の定量法 | |
EP1357194A2 (en) | Adapter for the connection of a biosensor to a measuring device | |
JP2001249103A (ja) | バイオセンサ | |
JP2004226358A (ja) | バイオセンサ | |
JP3267907B2 (ja) | バイオセンサおよびそれを用いた基質の定量法 | |
JP4036883B2 (ja) | バイオセンサ | |
JP2004004057A (ja) | バイオセンサ、それに用いるアダプタ、および測定装置 | |
JPH08338824A (ja) | バイオセンサ、バイオセンサの製造方法および特定化合物の定量法 | |
Taniike et al. | Biosensor | |
JP2004156989A (ja) | バイオセンサ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CN JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2002 514386 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10220153 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001948050 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018090451 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2001948050 Country of ref document: EP |